OncoPep
Latest round
- Series D
Last raised
- Dec 2021
Total raised
- $11M
Investors
- 4
About OncoPep
OncoPep, Inc. is a biotechnology company focused on developing innovative therapeutics to address unmet medical needs in oncology.OncoPep, Inc. was founded in 2010 in North Andover, US, and specializes in oncology therapeutics. The company has undergone strategic development to enhance its product offerings and has not reported any major pivots in its business operations. Jooeun Bae is the founder of OncoPep, while Doris Peterkin serves as the CEO.OncoPep specializes in developing innovative therapeutics aimed at addressing unmet medical needs within the oncology sector. Their primary offerings include a suite of proprietary drug candidates that are engineered to target specific cancer types, enhancing treatment efficacy while minimizing side effects. These products are designed for use by healthcare professionals in clinical settings, with end-users being patients diagnosed with various forms of cancer. The company's therapeutic solutions are aimed at improving patient outcomes, particularly in cases where conventional treatments have proven ineffective.OncoPep generates revenue primarily through direct sales of its therapeutic products to healthcare providers and institutions engaged in cancer treatment. The transactions are structured around a direct-to-consumer model, focusing on partnerships with hospitals and oncology practices that require innovative treatment options for their patients. Clients enter into agreements that outline product pricing, availability, and delivery schedules. While specific pricing details for products are not disclosed, the revenue structure emphasizes strategic collaborations and possibly subscription services for ongoing access to their drug candidates. The company is focused on designing and launching new therapeutic products tailored to specific cancer types, with anticipated releases aligned with its clinical trial progress. Additionally, OncoPep aims to expand its market presence beyond North America into select European regions, targeting key hospitals and oncology clinics by 2023.
Who invested in OncoPep
4 investors across 1 round
See all investors in OncoPep
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Dec 10, 2021
Amount
$11M
Investors
Questions about OncoPep
Who invested in OncoPep?
OncoPep has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OncoPep raised?
OncoPep has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did OncoPep last raise money?
OncoPep's most recent round on record is a Series D, in Dec 2021.
What does OncoPep do?
OncoPep is a pharmaceuticals company.
Where is OncoPep headquartered?
OncoPep is headquartered in North Andover, US.
Which VCs invest in companies like OncoPep?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at OncoPep's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like OncoPep? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.